Charles Elliott Sigal - 08 Jun 2022 Form 4 Insider Report for Surface Oncology, Inc. (SURF)

Role
Director
Signature
/s/ Jessica Fees, as Attorney-in-Fact
Issuer symbol
SURF
Transactions as of
08 Jun 2022
Transactions value $
$0
Form type
4
Filing time
10 Jun 2022, 20:00:48 UTC
Previous filing
25 May 2022
Next filing
01 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SURF Stock Option (Right to Buy) Award $0 +24K $0.00 24K 08 Jun 2022 Common Stock 24K $2.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Options shall vest in twelve equal monthly installments following the date of grant or, if earlier, upon the date of the next Annual Meeting; provided, however, that all vesting shall cease if the director resigns from the Board of Directors or otherwise ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting.